Industry
NICE Recommends Libtayo for Advanced Cervical Cancer in England and Wales
Around 90 women with advanced cervical cancer in the UK could be eligible for treatment with Regeneron's immunotherapy Libtayo each year, following a green light from NICE.
Industry
Irish Universities Association Launches Strategy 2026-2030 to Navigate Technological and Global Shifts
The IUA has unveiled its ambitious five-year strategy, built around five core priorities: Advocacy, Alignment, Agility, Access, and Accountability, aimed at securing the future of Ireland's higher education sector.
MedTech
Leading Digital Transformation in Ireland’s Pharma Sector: 5 Ways to Overcome Middle Management Resistance to AI
As Ireland’s pharma sector pivots toward Industry 4.0, middle management resistance to AI is a critical bottleneck. Here are 5 root causes of this pushback and targeted strategies to align your teams and drive digital transformation.
MedTech
How to Overcome Middle Management Resistance to AI in Ireland’s Pharma Sector: 5 Root Causes and Targeted Interventions
Middle managers stall more AI rollouts than bad technology does. Here are the 5 root causes of that resistance and the interventions that convert it to active advocacy within 90 days-specifically tailored for Ireland’s thriving Pharmaceutical and MedTech sectors.
Industry
Bridging the Gap: How WorkEqual is Empowering Women and Driving Workplace Equity in Ireland
An in-depth look at WorkEqual, its mission to help women (re)enter the Irish workforce, its national advocacy for gender parity, and the new WorkAbility Programme supporting people with disabilities.
Biotechnology
A Biotech Buying Frenzy: Inside the H1 2026 Pharma M&A Surge
An in-depth analysis of the massive wave of pharmaceutical mergers and acquisitions in the first half of 2026, driven by patent cliffs, pipeline replenishment, and high-growth therapeutic areas.
Pharmaceutical
The Innovation Exodus: Why Europe Must Rethink Medicine Pricing or Risk Losing Life Science Investments
An in-depth analysis of the warnings from pharmaceutical lobby chief Stefan Oelrich regarding European cost-cutting reforms, global pricing shifts, and the threat to clinical research and manufacturing.
Pharmaceutical
Scaling Ireland’s Biopharma Leadership: Inside Eli Lilly’s $2.8 Billion Manufacturing Expansion in Limerick and Kinsale
An in-depth analysis of Eli Lilly’s massive manufacturing footprint in Limerick and Kinsale, highlighting local jobs, high-tech biologic drug production, and Ireland’s strategic position in the global biopharma supply chain.
Pharmaceutical
Roche Seeks Buyer for Former Manufacturing Site in Clarecastle, Co Clare - €4m Price Tag
Swiss pharma giant Roche has appointed Cushman & Wakefield to sell its 88-acre decommissioned manufacturing facility in Clarecastle, Co Clare, with an expected asking price of €4 million, following a €150m remediation programme.
Industry
Ireland Tightens Family Reunification Rules: Higher Income Thresholds, Housing Checks and Stricter Relationship Scrutiny
The Irish Department of Justice has overhauled its family reunification framework, raising the income requirement for Irish citizen sponsors to €75,000 over three years, introducing housing sufficiency checks, and imposing a new two-year waiting period for refugees. Here is everything migrants and families in Ireland need to know.
Pharmaceutical
Status Yellow High Temperature Warning Issued for Ireland - Your Complete Health & Safety Guide
Met Éireann has issued a Status Yellow High Temperature Warning for Ireland. Here is everything you need to know: how to protect yourself and your family, what to eat and drink, what to keep at home, and the key precautions recommended by HSE and public health experts.
LinkedIn
LinkedIn for Medical Science Liaisons (MSLs): The Complete Guide to Showcasing Scientific Expertise Without Violating Compliance
A step-by-step compliance-safe LinkedIn guide exclusively for Medical Science Liaisons. Covers profile optimisation, what to post, what never to post, KOL engagement, off-label rules, digital medical affairs strategy, and how to build scientific credibility on LinkedIn without breaching pharmaceutical regulatory guidelines.